|
|
News ReleasesAnavex presents data on neuroprotective evidence for ANAVEX 2-73, lead compound for Alzheimer's disease2011-07-26 Dr. Cameron Durrant, MD, MBA, Alzheimer's Disease and Pharmaceuticals/Biot Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL) is pleased to provide a summary of its second poster presentation at the Alzheimer’s Association International Conference (AAIC) held in Paris, enti... Anavex presents data on potential dual utility of ANAVEX 2-73 in both amyloid and tau pathology2011-07-25 Dr. Cameron Durrant, MD, MBA, Alzheimer's Disease and Pharmaceuticals/Biot Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL) is pleased to provide a summary of the first of two poster presentations at the Alzheimer’s Association International Conference (AAIC) held in Pari... Anavex raises $1.575 million2011-07-11 Dr. Cameron Durrant, MD, MBA, Alzheimer's Disease and Pharmaceuticals/Biot Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL) is pleased to announce that it has raised US$1,575,000.00 through the exercise of warrants. Funds will be used to continue the Phase I clinical tria... Anavex to present at Alzheimer’s Association International Conference on Alzheimer's Disease2011-07-15 Dr. Cameron Durrant, MD, MBA, Alzheimer's Disease and Pharmaceuticals/Biot Anavex Life Sciences Corp. (“Anavex”) (OTCBB: AVXL) today announced that new data on ANAVEX 2-73, the company’s lead compound for Alzheimer’s disease (AD) currently in Phase I clinical trials, will be... Herb/Drug Interactions: What You Don't Know CAN Hurt You2010-05-04 The Canadian College of Naturopathic Medicine Can combining prescription antidepressants and herbal medicine put your life at risk? Misconceptions abound when it comes to combining herbal medications and conventional drugs. Naturopathic doctors c... Sources Select ResourcesBad Pharma, Bad Journalism Cromwell, David Article 2012 Media Lens ‘The drugs don't work: a modern medical scandal’, from Ben Goldacre's new book, Bad Pharma presents a disturbing picture emerges of corporate drug abuse. Sources BookshelfPrivate Profits vs Public PolicyThe Pharmaceutical Industry and the Canadian State Lexchin, Joel Book 2016 According to Joel Lexchin, "Given the central role that medicines play in keeping us healthy, it is essential that we understand the policy environment that governs drug development, from the initial ... |
|
Sources is an online portal and directory for journalists, writers, news editors, researchers. Use Sources to find experts, media contacts, spokespersons, scientists, lobbyists, officials, speakers, university professors, researchers, newsmakers, CEOs, executive directors, media relations contacts, spokespeople, talk show guests, PR representatives, Canadian sources, story ideas, research studies, databases, universities, colleges, associations, businesses, government, research institutions, lobby groups, non-government organizations (NGOs), in Canada and internationally.
© Sources 1977-2021. The information provided is copyright and may not be reproduced in any form or by any means (whether electronic, mechanical or photographic), or stored in an electronic retrieval system, without written permission of the publisher. The content may not be resold, republished, or redistributed. Indexing and search applications by Ulli Diemer and Chris DeFreitas.
|
Sources Calendar